John Salisbury, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 700 West Kent, Missoula, MT 59806 Phone: 406-541-3804 Fax: 406-541-1810 |
Dr. David P Mccann, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 700 West Kent, Missoula, MT 59801 Phone: 406-541-3937 Fax: 406-541-3811 |
Scott M Guess, M.D. Ophthalmology - Retina Specialist Medicare: Accepting Medicare Assignments Practice Location: 700 W. Kent, Missoula, MT 59801 Phone: 406-541-3918 Fax: 406-541-3918 |
Brian Douglas Sippy, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 700 W Kent Ave, Missoula, MT 59801 Phone: 406-541-3804 Fax: 406-541-1810 |
Dr. Joe Glickman Jr., M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 142 Morrison Rd, Whitefish, MT 59937 Phone: 406-250-9831 |
News Archive
Baxter International Inc. and Nycomed today announced the U.S. Food and Drug Administration (FDA) approval of TachoSil (Absorbable Fibrin Sealant Patch) for use as an adjunct to hemostasis in cardiovascular surgery. TachoSil is the first and only adjunctive hemostatic agent available in the U.S. that combines a collagen patch with a coating of human coagulation factors.
Dr Rifat Atun, Director of Centre for Health Management at Imperial College's Tanaka Business School has been appointed to chair a new World Health Organization (WHO) Task Force on Health System Strengthening and Tuberculosis Control. The initiative is led by the WHO's Stop TB Department.
CRISPRainbow, a new technology using CRISPR/Cas9 developed by scientists at UMass Medical School, allows researchers to tag and track up to seven different genomic locations in live cells. This labeling system, details of which were published in Nature Biotechnology, will be an invaluable tool for studying the structure of the genome in real time.
Breastfeeding does not protect children against developing asthma or allergies, says a new study led by McGill University's Dr. Michael Kramer and funded by the Canadian Institutes of Health Research (CIHR).
Accuray Incorporated, a global leader in the field of radiosurgery, today announced the expiration of the mandatory, pre-merger waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976, in connection with the previously announced acquisition of TomoTherapy Incorporated.
› Verified 4 days ago